Jayavaradhan, R., Pillis, D. M., Goodman, M., Zhang, F., Zhang, Y., Andreassen, P. R., & Malik, P. (2019). CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites. Nature Portfolio.
Style de citation Chicago (17e éd.)Jayavaradhan, Rajeswari, Devin M. Pillis, Michael Goodman, Fan Zhang, Yue Zhang, Paul R. Andreassen, et Punam Malik. CRISPR-Cas9 Fusion to Dominant-negative 53BP1 Enhances HDR and Inhibits NHEJ Specifically at Cas9 Target Sites. Nature Portfolio, 2019.
Style de citation MLA (8e éd.)Jayavaradhan, Rajeswari, et al. CRISPR-Cas9 Fusion to Dominant-negative 53BP1 Enhances HDR and Inhibits NHEJ Specifically at Cas9 Target Sites. Nature Portfolio, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.